Science by the Pint: "Zero to One: Commercializing the First Non-Human Organ Transplant" (CANCELLED)
When:
Monday, Dec 02, 2019 6:30p -
8:00p
Monday, Dec 02, 2019 6:30p -
8:00p
Where:
Saloon
255 Elm St
Somerville, MA 02144
Admission:
FREE
Categories:
Alcohol, Date Idea, Food, Innovation, Lectures & Conferences, Meetup, Tech
Event website:
http://sitn.hms.harvard.edu/science-by-the-pint/
ATTENTION!
THE BELOW EVENT HAS BEEN CANCELLED FOR THIS EVENING DUE TO INCLEMENT WEATHER CONDITIONS. PLEASE SEE OUR WEBSITE FOR FURTHER INFORMATION AND FUTURE EVENT INFORMATION.
-------------------------------------------------------------
Science by the Pint is a free science "café" hosted by members of the Harvard Graduate School of Arts and Science's Science in the News organization. We give our audience a chance to hear about what's happening at the cutting edge of science in a fun and unique way: by sharing a drink (alcohol optional) and chatting face-to-face with a Boston-area scientist. The events are geared toward a general audience – all are welcome and no experience is necessary!
This week we are featuring...
Xeno Therapeutics
With guest speakers:
Paul Holzer, MEng, MS, MBA (Chief Executive Officer)
Jon Adkins, MBA (Chief Operating Officer)
Elizabeth Chang (Preclinical ResearchDirector)
Pooja Asedara (Clinical Trial Coordinator)
Xeno Therapeutics is a clinical-stage biotechnology company with a platform focused on the immunogenomic reprogramming of foreign cells for the purpose of transplanting organs and tissues from other species into human patients. Combining fundamental principles with proven technologies, Xeno aims to provide “humanized” organs and tissues to serve all humankind. Their first product towards this goal, Xeno-Skin, is currently being applied to the treatment of severe burn patients. Human skin transplant material, the current standard of care, is limited and takes significant time for hospitals to acquire, during which these patients are extremely vulnerable to infection and fluid loss due to their disrupted skin barrier. Xeno-Skin is designed to act as a “living bandage” that can be mass-produced and shipped rapidly, helping bridge the gap during this critical period. Xeno-skin is currently completing a Phase I clinical evaluation and was used as part of the first FDA-cleared non-human organ transplant, performed at Massachusetts General Hospital earlier this year. Their related follow-up product, Xeno-Nerve, is anticipated for clinical evaluation in 2020.
Come hear from four members of Xeno’s management and scientific team about their efforts to bring xenotransplantation into modern medical practice, along with all the scientific and business-related challenges they’ve faced along the way!
Specific Bar Directions:
Follow the street-level sign for The Rockwell, located between Foundry on Elm and The Burren. Proceed through the “wooden” door and down the main staircase, then turn left at the bottom of the stairs to enter Saloon. We will be in the side room space, adjacent to the main bar.
